相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diarrhea Is a Positive Outcome Predictor for Sorafenib Treatment of Advanced Hepatocellular Carcinoma
Ronald Koschny et al.
ONCOLOGY (2013)
Transplantation for Hepatocellular Carcinoma in Younger Patients Has an Equivocal Survival Advantage as Compared With Resection
J. A. Graham et al.
TRANSPLANTATION PROCEEDINGS (2013)
ESMO-JSMO - Recent advances in the treatment of GI tract and liver cancer in the EU and Japan
J. Furuse et al.
ANNALS OF ONCOLOGY (2012)
Real-Life Clinical Practice with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Center Experience
Masatoshi Kudo et al.
DIGESTIVE DISEASES (2012)
Long-term results of sorafenib in advanced-stage hepatocellular carcinoma: what can we learn from routine clinical practice?
Rodolfo Sacco et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Hepatocellular Carcinoma Confirmation, Treatment, and Survival in Surveillance, Epidemiology, and End Results Registries, 1992-2008
Sean F. Altekruse et al.
HEPATOLOGY (2012)
EFFICACY AND TOXICITY OF METRONOMIC CAPECITABINE IN ADVANCED HEPATOCELLULAR CARCINOMA
A. Farrag
JOURNAL OF HEPATOLOGY (2012)
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2012)
Early Sorafenib-Induced Toxicity Is Associated with Drug Exposure and UGTIA9 Genetic Polymorphism in Patients with Solid Tumors: A Preliminary Study
Pascaline Boudou-Rouquette et al.
PLOS ONE (2012)
Hepatitis C virus and other risk factors in hepatocellular carcinoma
E. Schiefelbein et al.
ACTA VIROLOGICA (2012)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Sorafenib in Hepatocellular Carcinoma: Separating the Hype From the Hope
Robin K. Kelley et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma
YZ Patt et al.
CANCER (2004)
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
J Bruix et al.
JOURNAL OF HEPATOLOGY (2001)
分享论文
